
#D13TS_Picks
#EVTC: Q2 revenue grew 20% YoY to $274.8M, with raised FY2026 guidance and expansion across Latin America.
For detailed analysis: https://t.me/c/2454754655/10521
#KVYO: Q2 revenue rose 26% YoY to $370.6M, supported by AI-driven marketing growth and raised FY2026 guidance.
For detailed analysis: https://t.me/c/2454754655/10530
#MLYS: Promising Phase 3 blood-pressure results and strong cash reserves support its potential, with an FDA decision expected December 22, 2026.
For detailed analysis: https://t.me/c/2454754655/10533
👉 Join our ThinkSabio Stocks WL999 Group
To join, simply visit our ThinkSabio Community Page or access the ThinkSabio Bot.
🌐 https://www.thinksabio.com/community


Share this post
💬 Comments
Loading comments…
Leave a comment
